1. Home
  2. CSBR vs IXHL Comparison

CSBR vs IXHL Comparison

Compare CSBR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.34

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.30

Market Cap

97.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
IXHL
Founded
1985
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
97.6M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
CSBR
IXHL
Price
$6.34
$3.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7K
3.6M
Earning Date
06-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
161.11
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
$12,000.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$0.11
52 Week High
$10.25
$6.39

Technical Indicators

Market Signals
Indicator
CSBR
IXHL
Relative Strength Index (RSI) 50.42 56.76
Support Level $6.11 $0.31
Resistance Level $6.24 $5.17
Average True Range (ATR) 0.21 0.54
MACD 0.06 -0.06
Stochastic Oscillator 78.75 50.60

Price Performance

Historical Comparison
CSBR
IXHL

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: